ANGLE plc Revenue and Competitors
Estimated Revenue & Valuation
- ANGLE plc's estimated annual revenue is currently $48.2M per year.
- ANGLE plc's estimated revenue per employee is $251,000
Employee Data
- ANGLE plc has 192 Employees.
- ANGLE plc grew their employee count by 9% last year.
ANGLE plc's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Cell Biology, Technology Transfer and Operations | Reveal Email/Phone |
3 | SVP Commercial Operations | Reveal Email/Phone |
4 | Head Medical Writing and Corporate Insight | Reveal Email/Phone |
5 | Head Clinical Laboratories | Reveal Email/Phone |
6 | VP Engineering | Reveal Email/Phone |
7 | Head Medical Writing and Corporate Insight | Reveal Email/Phone |
8 | Chief Commercial Officer (CCO) | Reveal Email/Phone |
9 | Regional Business Director ANGLE plc | Reveal Email/Phone |
10 | Director Operations and Regulatory Affairs | Reveal Email/Phone |
ANGLE plc Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $86.6M | 345 | 2% | N/A | N/A |
#2 | $369.5M | 920 | -23% | $974.7M | N/A |
#3 | $1M | 4 | 0% | N/A | N/A |
#4 | $258.8M | 1031 | 18% | N/A | N/A |
#5 | $136M | 542 | 8% | N/A | N/A |
#6 | $19.8M | 79 | -2% | N/A | N/A |
#7 | $51.7M | 206 | 7% | N/A | N/A |
#8 | $40.9M | 163 | 10% | N/A | N/A |
#9 | $85.1M | 339 | 9% | N/A | N/A |
#10 | $40.4M | 161 | 8% | N/A | N/A |
What Is ANGLE plc?
ANGLE plc is a specialized medical diagnostics company with products in the cancer diagnostics and fetal health markets. \r\n\r\nANGLE plc’s lead product, the Parsortix cell separation system, captures very rare cells from blood. \r\n\r\nThis includes circulating tumor cells (CTCs) in cancer patient blood – even when there is less than one CTC\r\nper billion healthy cells. \r\n\r\nThe resulting liquid biopsy allows investigation of mutations in the patient’s cancer, and enables precision medicine. ANGLE plc has launched a product for the research market and has secured CE Mark regulatory approval for the clinical market in Europe. The FDA approval process is underway for the clinical market in the US.
keywords:N/A
N/A
Total Funding
192
Number of Employees
$48.2M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ANGLE plc News
Published: Apr 20, 2022. GUILDFORD, UK / ACCESSWIRE / April 20, 2022 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company,...
GUILDFORD, UK / ACCESSWIRE / April 14, 2022 / ANGLE plc ("the Company") (AIM:AGL),(OTCQX:ANPCY), a world-leading liquid biopsy company,...
ANGLE is a world leading liquid biopsy company with sample-to-answer solutions. ANGLE's proven patent protected platforms include a circulating...
Transforming cancer care with a liquid biopsy based on a simple blood test ANGLE plc Interim Report for the six months ended 30 June 2021 ANGLE plc Interim Results ANGLE plc (AIM:AGL OTCQX:ANPCY), a world leading liquid biopsy company, released on 30 September 2021, its unaudited interim fin ...
Interim results for the six months ended 30 June 2021 Andrew Newland and Ian Griffiths 30 September 2021 LSE AIM:AGL OTCQX:ANPCY Legal disclaimer This presentation has been prepared by ANGLE plc (the "Company"). By attending this presentation and/or reviewing the slides you agree to be bou ...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $30.6M | 192 | N/A | N/A |
#2 | $30.6M | 192 | N/A | N/A |
#3 | $37M | 192 | 5% | N/A |
#4 | $38M | 192 | 5% | N/A |
#5 | $46.5M | 192 | 7% | N/A |